Back to top

Crinetics Faces Shareholder Challenges to Vertex Merger Deal

An update from Crinetics Pharmaceuticals ( ($CRNX) ) is now available. On July 6, 2026, Crinetics agreed to be acquired by Vertex Pharmaceuticals v...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Crinetics Pharmaceuticals, Inc. (CRNX)